New EU regulation has made the medtech industry turn to the US
As a direct consequence of new EU regulation for the medtech industry, firms have started to launch in the US before Europe, which wasn’t always the case previously, says the chief executive of industry association Medtech Europe.
by ulrich quistgaard, translated by daniel pedersen
New European requirements for medical devices have meant that the medtech industry has begun launching products in the US before Europe, according to Serge Bernasconi, the chief executive of industry organization Medtech Europe.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
